Clinical trial
Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer…
NCT00378131 · Helsinn Therapeutics (U.S.), Inc, Industry · Completed
Key facts
| NCT number | NCT00378131 |
|---|---|
| Title | Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/Cachexia |
| Official title | A 12-Week, Double-Blind, Randomized, Placebo-Controlled, Parallel Group Phase II Study Comparing the Safety, Tolerability and Beneficial Effects of Daily Doses of RC-1291 and Placebo in Patients With Cancer Anorexia/Cachexia |
| Lead sponsor | Helsinn Therapeutics (U.S.), Inc, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cancer Cachexia |
| Intervention type | Drug |
| Interventions | RC-1291, placebo |
| Enrollment | 51 |
| Start date | Sep 1, 2006 |
| Primary completion | Apr 1, 2007 |
| Completion | Apr 1, 2007 |
| First posted | Sep 19, 2006 |
| Last update posted | Sep 2, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: